On 14 November 2017
Mesco Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 14 November 2017, to inter-alia consider and approve Unaudited Financial Results pursuant to Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulation 2015 for the quarter and half year ended 30th September, 2017.Powered by Capital Market - Live News